🟢 Tenax Therapeutics is trading 5.83% up; no verified company explanation surfaced

Tenax Therapeutics is trading at $1.73, up 5.83%, with no verified company announcement explaining the gain.

• A report published October 22 disclosed that major shareholder Adar1 Capital Management bought 331,979 shares on October 21 for about $551,085.
• The filing does not establish that the purchase caused the rise.
• The broader market context is sharply negative and does not explain Tenax Therapeutics’ move higher.